Cicconi, Laura
Platzbecker, Uwe
Avvisati, Giuseppe
Paoloni, Francesca
Thiede, Christian
Vignetti, Marco
Fazi, Paola
Ferrara, Felicetto
Divona, Mariadomenica
Albano, Francesco http://orcid.org/0000-0001-7926-6052
Efficace, Fabio
Sborgia, Marco
Di Bona, Eros
Breccia, Massimo
Borlenghi, Erika http://orcid.org/0000-0002-4666-3817
Cairoli, Roberto
Rambaldi, Alessandro http://orcid.org/0000-0002-3739-7502
Melillo, Lorella
La Nasa, Giorgio
Fiedler, Walter
Brossart, Peter
Hertenstein, Bernd
Salih, Helmut R.
Annibali, Ombretta
Wattad, Mohammed
Lubbert, Michael
Brandts, Christian H.
Hanel, Mathias
Rollig, Christoph
Schmitz, Norbert
Link, Hartmut
Frairia, Chiara
Fozza, Claudio
Maria D’Arco, Alfonso
Di Renzo, Nicola
Cortelezzi, Agostino
Fabbiano, Francesco
Dohner, Konstanze
Ganser, Arnold
Dohner, Hartmut
Amadori, Sergio
Mandelli, Franco
Voso, Maria Teresa http://orcid.org/0000-0002-6164-4761
Ehninger, Gerhard
Schlenk, Richard F.
Lo-Coco, Francesco
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (5916)
Article History
Received: 24 May 2019
Revised: 31 July 2019
Accepted: 13 August 2019
First Online: 14 October 2019
Compliance with ethical standards
:
: LC, Speakers’ Bureau: Teva Pharmaceutical Industries; UP, Honoraria and Research Funding: Teva Pharmaceutical Industries; CT, Employment: AgenDix; FE, Advisory Role: Teva Pharmaceutical Industries, Research Funding: Lundbeck (Inst); HL, Honoraria and Research Funding: Teva Pharmaceutical Industries; RFS, Honoraria and Research Funding: Teva Pharmaceutical Industries; FL-C, Honoraria: Teva Pharmaceutical Industries, Lundbeck, Consulting or Advisory Role: Teva Pharmaceutical Industries, Lundbeck. Other authors declared that they have no conflict of interest.